Paediatric Vaccinations
The first dose is given at the age of 2 months, the second dose at the age of 4 months, the third dose at the age of 6 to 18 months, and the fourth dose at age 4 to 6 years. Diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: Before age 7, children are given the DTaP preparedness. Five doses of DTaP are given.
Related Conference of Paediatric Vaccinations
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Paediatric Vaccinations Conference Speakers
Recommended Sessions
- Allergy and Therapies
- Allergy, Hypersensitivity and Asthma
- Animal & Plant-Derived Vaccines
- Autoimmune Disorders
- Cancer Immunology and Immunotherapy
- Cellular Immunology and Latest Innovations
- Child Immunization and Vaccination Viral Immunology
- Clinical Immunology: Current & Future Research
- DNA & Synthetic Conjugate Vaccines Travel & Edible Vaccines
- Genetics Immunology & Vaccinology
- Geriatric Immunizations
- Haematopoietic and Lymphoid Malignancies and Immune System Development
- Immunologic Techniques, Microbial Control and Therapeutics
- Infectious Diseases, Emerging and Re-emerging Diseases: Confronting Future Outbreaks
- Neuro Immunology
- Paediatric Vaccinations
- Pathology and Immunology
- Pediatric Immunology
- Stem Cell Immunology
- Vaccines for Immune Mediated Diseases
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (Italy)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (Italy)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Epidemiology - European Immunology 2025 (Italy)
- Immune System - European Immunology 2025 (Italy)
- Immunodeficiency - European Immunology 2025 (Italy)
- Immunogenetics - European Immunology 2025 (Italy)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (Italy)
- Immunological Techniques - European Immunology 2025 (Italy)
- Immunology - European Immunology 2025 (Italy)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunotherapy - European Immunology 2025 (Italy)
- Immunotoxicology - European Immunology 2025 (Italy)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Neuroimmunology - European Immunology 2025 (Italy)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Parasite Immunology - European Immunology 2025 (Italy)
- Pediatrics Immunology - European Immunology 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Reproductive Immunology - European Immunology 2025 (Italy)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Transplantation Immunology - European Immunology 2025 (Italy)
- Viral Immunology - European Immunology 2025 (Italy)